Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 18 of 18 for “"Flecainide"”.
-
The action of flecainide on the wild-type cardiac ryanodine receptor
… fatal arrhythmias during stress or exercise. Flecainide, a class 1C sodium channel (Nav1.5) inhibitor and anti-arrhythmic agent, was recently observed to be effective against CPVT arrhythmias. Controversially, it was suggested that flecainide acted directly on RyR2, alongside its action on …
-
Defining the molecular cause of an altered response to anti-arrhythmic drugs in Pitx2-dependent atrial fibrillation
… potential (RMP) and an enhanced sensitivity to flecainide. In this thesis, the causes of the modification in atrial electrophysiology and response to antiarrhythmic drug (AAD) therapy in Pitx2c+/- mice were studied. Methods: Sodium currents (INa), potassium currents (IKpeak, IKsteadystate, Ito, …
-
Electrophysiological differences in atria and ventricles
… rhythm. Current anti-arrhythmic drugs such as flecainide, do not specifically target atrial sodium channels, and information on electrophysiological differences between atria and ventricles is limited. Furthermore, flecainide is contraindicated in ischaemic heart disease (IHD) patients due to …
-
Distinct properties of the atrial voltage-gated sodium channel
… initiated from physiological holding potentials. Flecainide sodium channel inhibition was greater in LA than LV, likely also due to differences in kinetic properties of the sodium channels between chambers. Additionally, the greater inhibitory effect of flecainide at more positive membrane …
-
Optical imaging of cardiac atrial activation and repolarisation in genetically altered models
… effect of the sodium channel blocker, flecainide, to the left atrium of Pitx2c\(^+\)\(^/\)\(^-\) mice. A second mouse model was used to mimic arrhythmogenic right ventricular cardiomyopathy (plako\(^+\)\(^/\)\(^-\)). No significant changes were witnessed in young sedentary cohorts at …
-
STUDIES TOWARD THE TOTAL SYNTHESIS OF ALTEMICIDIN AND PHOTOPHARMACOLOGICAL CONTROL OF NAV1.5
… of the Class Ic antiarrhythmic drugs flecainide and encainide, two light-responsive derivatives—azo-flecainide and azo-encainide—were developed. These molecules undergo reversible trans–cis photoisomerization under light irradiation, enabling optical modulation of their molecular …
-
Relationship between ischaemia-selective drug action and antiarrhythmic efficacy
… antiarrhythmic drugs (quinidine, lidocaine, flecainide and tedisamil) were compared to those of the novel drug RSD1019, under conditions designed to mimic, or produce, myocardial ischaemia in rat hearts. In support of the hypothesis, drugs which exhibited selectivity for the conditions of …
-
Η ΠΡΟΛΗΠΤΙΚΗ ΑΝΤΙΑΡΡΥΘΜΙΚΗ ΘΕΡΑΠΕΙΑ ΣΤΗΝ ΟΞΕΙΑ ΦΑΣΗ ΤΟΥ ΕΜΦΡΑΓΜΑΤΟΣ ΜΥΟΚΑΡΔΙΟΥ:ΑΙΜΟΔΥΝΑΜΙΚΗ ΣΥΓΚΡΙΤΙΚΗ ΜΕΛΕΤΗ ΜΕΤΑΞΥ ΝΕΩΝ ΟΥΣΙΩΝ: ΣΙΒΕΝΖΟΛΙΝΗ, ΦΛΕΚΑΙΝΙΔΗ,ΜΕΞΙΛΕΤΙΝΗ,ΠΡΟΠΑΦΑΙΝΟΝΗ.
… OF FOUR ANTIARRHYTHMIC DRUGS:CIBENZOLINE (C), FLECAINIDE (F), MEXILETINE (M), AND PROPAFENONE (P). METHODS: THESE DRUGS WERE GIVEN RANDOMLY, SINGLE BLINDED, PLACEBO (PBO) CONTROLLED IN109 PTS, 58 MALE, 51 FEMALE, AGED 72.2+-12.1 (+-SD). ALL PTS WERE TREATED WITH BASIC CONVENTIONAL THERAPY PLUS …
-
Desarrollo y caracterización de formulaciones farmacéuticas adaptadas para pediatría: medicamentos antituberculosos
… have been tested. Individualized medicine of Flecainide, Dexamethasone, Furosemide and Acetazolamide have been selected based on their demand, problems that arose during elaboration and the excipients used. In all cases, a new standard operative procedure, which ensures the quality of the …
-
Deciphering inheritable drivers of atrial arrhythmia - from cellular microdomains in models to phenotypes in patients
… to the clinically used sodium channel blocker flecainide. Our findings underline that murine models represent a valuable tool to decipher drivers of atrial arrhythmia seen in patients.
-
Multiscale human-based computer modelling and simulation for investigations of arrhythmic risk in acute ischemia
… use of pharmacological treatments. For instance, flecainide is a Na<sup>+</sup> channel blocker commonly used for treating atrial fibrillation, but its effects have been proven to increase mortality among ischemic patients, as observed in the CAST trials.</p> <p>Although electrophysiological …
-
Supraventrikulinės tachikardijos gydymas nėštumo laikotarpiu. Klinikinis atvejis. Literatūros analizė /
… verapamil alone. If these drugs are ineffective, flecainide or propafenone may be prescribed, which are also recommended for pregnant women with Wolf-Parkinson-White syndrome, and without structural or ischaemic heart disease. Fluoroless catheter ablation can be performed from the second trimester …
-
Mechanisms of phenotypic diversity in cardiac sodium channelopathies modelled with induced pluripotent stem cell derived cardiomyocytes
… which was sensitive to NaV1.5 inhibition with flecainide and lidocaine. Variation in conduction velocity between differentiations was also correlated with levels of SCN5A mRNA expression (r2 = 0.48). Heterozygous SCN5A-E1784K mutant iPSC-CMs showed reduced conduction velocity and prolonged …
-
Calcium cycling disturbances and arrhythmogenesis
… arrhythmias in CPVT by the pharmacological agent flecainide was found to be due to its effect on mean open time of RyR rather than due to its effect on blocking the fast Na current (INa). However, such preventive action was not associated with abolition of Ca waves. EADs and TA also occurred in a …
-
Molecular Mechanisms of Physalia Physalis Venom Modulation of Cardiac and Vascular Functions
… under the influence of P. physalis venom. Flecainide (a sodium channel blocker) and verapamil do not inhibit the increased sodium influx. The venom may accelerate sodium/calcium exchange directly and/or indirectly by increased calcium influx, the major mechanism for the embryonic chick …
-
Genetic Engineering of Excitable Cells for In Vitro Studies of Electrophysiology and Cardiac Cell Therapy
… I<sub>Na</sub> inhibition by TTX, lidocaine, or flecainide. Furthermore, expression of the Na<sub>v</sub>1.5 A1924T mutant sodium channel or Ca<sub>v</sub>3.3 T-type calcium channel was utilized to study the specific roles of these channels in action potential conduction and demonstrate that …
-
Sodium Channel Loss of Function Sensitizes Conduction to Changes in Extracellular Sodium Concentration
Sudden cardiac death is largely attributable to sudden onset ventricular arrhythmias. Alterations in cardiac conduction, particularly the slowing of conduction velocity is one major factor in arrhythmogenesis. By understanding the mechanisms and factors that modulate cardiac conduction velocity, we …
-
Φαρμακευτική έναντι ηλεκτρικής ανάταξης σε ασθενείς με κολπική μαρμαρυγή στο τμήμα επειγόντων περιστατικών: συσχέτιση με βιοχημικούς δείκτες και πρόγνωση ασθενών
Background:Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF recurrence or persistence on the 8th (D8) and 30th …